MH Elberry, NHE Darwish, SA Mousa (2017) Hepatitis C virus management: Potential impact of nanotechnology, Virol J, 14:88.
P Gladfelter, NHE Darwish, SA Mousa (2017) Current status and future direction in the management of malignant melanoma, Melanoma Res, 27:403-410.
JW Potts, SA Mousa (2017) Recent advances in management of autosomal-dominant polycystic kidney disease, Am J Health Syst Pharm, 74:1959-1968.
ZT Sahli, J Jo, SA Mousa, FI Tarazi (2017) Clinical management of restless legs syndrome in end-stage renal disease patients, CNS Spectr, 22:14-21.
LA Della Badia, NA Elshourbagy, SA Mousa (2016) Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol, Pharmacol Ther, 164:183-194.
SM Brady, L Shapiro, SA Mousa (2016) Current and future direction in the management of scleroderma, Arch Derm Res, 308:461-471.
BR Yasin, HA El-Fawal, SA Mousa (2015) Date (Phoenix dactylifera) polyphenolics and other bioactive compounds: A traditional islamic remedy’s potential in prevention of cell damage, cancer therapeutics and beyond, Int J Mol Sci, 16:30075-30090.
NE Larche, SA Mousa (2013) Riociguat for the Management of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Drugs of Today (Barc) 49:761-768. http://www.ncbi.nlm.nih.gov/pubmed/24524094
AY Kardys, DJ Bharali, SA Mousa (2013) Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer. Journal of Nanotechnology DOI 10.1155/2013/768724. http://www.hindawi.com/journals/jnt/2013/768724/
NJ Rogers, SA Mousa (2012) The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome. Journal of Alternative and Complementary Medicine 18:112-119. http://www.ncbi.nlm.nih.gov/pubmed/22339099
H Patel, M Qari, SA Mousa (2012) Iron Balance in Β-Thalassemia: Maintaining an Antioxidant / Oxidant Ratio. Journal of Applied Hematology 3:4-11. Iron Balance in B-Thalassemia
JC Keimer, SA Mousa (2012) Expanding the Role of Community Pharmacy: An Evaluation of Generic Drug Discount Programs, Pharmacy Based Immunization Services and Convenient Care Clinics. International Journal of Pharmacy 2:1-7. Expanding the Role of Community Pharmacy
J Ramli, P CalderonArtero, RC Block, SA Mousa (2011) Novel Therapeutic Targets for Preserving a Healthy Endothelium: Strategies for Reducing the Risk of Vascular and Cardiovascular Disease. Cardiology Journal 18:352-363. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342824/
AA Abd-Rabou, DJ Bharali, SA Mousa (2018) Taribavirin and 5-fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking, and antiproliferative effects on MCF-7 breast cancer, Pharm Res, 35:76.
PJ Davis, JL Leonard, HY Lin, M Leinung, SA Mousa (2018) Molecular basis of nongenomic actions of thyroid hormone, Vitam Horm, 106:67-96.
A Hercbergs, SA Mousa, PJ Davis (2018) Nonthyroidal illness syndrome and thyroid hormone actions at integrin αvβ3, J Clin Endocrinol Metab, Feb. 1, 2018 [Epub ahead of print].
A Hercbergs, SA Mousa, M Leinung, HY Lin, PJ Davis (2018) Thyroid hormone in the clinic and breast cancer, Horm Cancer, Feb. 13, 2018 [Epub ahead of print].
AW Nana, YT Chin, CY Lin, Y Ho, JA Bennett, YJ Shih, YR Chen, CA Changou, JZ Pedersen, S Incerpi, LF Liu, J Whang-Peng, E Fu, WS Li, SA Mousa, HY Lin, PJ Davis (2018) Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer, Endocr Relat Cancer, 25:279-293.
DJ Bharali, T Sudha, H Cui, BM Mian, SA Mousa (2017) Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer, Nanomedicine, 13:263-273.
L Fu, K Li, D Mori, M Hirakane, L Lin, N Grover, P Datta, Y Yu, J Zhao, F Zhang, M Yalcin, SA Mousa, JS Dordick, RJ Linhardt (2017) Enzymatic generation of highly anticoagulant bovine intestinal heparin, J Med Chem, 60:8673-8679.
MT Hsieh, LM Wang, CA Changou, YT Chin, YSH Yang, HY Lai, SY Lee, YN Yang, J Whang-Peng, LF Liu, HY Lin, SA Mousa, PJ Davis (2017) Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells, Oncotarget, 8:24237-24249.
JT Leith, PJ Davis, SA Mousa, AA Hercbergs (2017) In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells, Cell Cycle, 16:367-373.
W Li, M Yalcin, Q Lin, MM Ardawi, SA Mousa (2017) Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery, J Control Release, 248:117-124.
V Muralidharan-Chari, J Kim, SA Mousa (2017) Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-L-lysine: A comparative ‘in vitro’ study versus protamine sulfate, Thromb Res, 155:128-130.
S Nallanthighal, C Chan, DJ Bharali, SA Mousa, E Vasquez, R Reliene (2017) Particle coatings but not silver ions mediate genotoxicity of ingested silver nanoparticles in a mouse model, NanoImpact, 5:92-100.
M Rajabi, SA Mousa (2017) The role of angiogenesis in cancer treatment, Biomedicines, 5:34.
M Srinivasan, DJ Bharali, T Sudha, M Khedr, I Guest, S Sell, GV Glinsky, SA Mousa (2017) Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation, Oncotarget, 8:38731-38742.
T Sudha, DJ Bharali, S Sell, NHE Darwish, PJ Davis, SA Mousa (2017) Nanoparticulate tetrac inhibits growth and vascularity of glioblastoma xenografts, Horm Cancer, 8:157-165.
T Sudha, DJ Bharali, M Yalcin, NH Darwish, MD Coskun, KA Keating, HY Lin, PJ Davis, SA Mousa (2017) Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac, Nanomed(Lond), 12:195-205.
NHE Darwish, T Sudha, K Godugu, O Elbaz, HA Abdelghaffar, EEA Hassan, SA Mousa (2016) Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: Potential impact of BMI-1, TIM-3 and CLL-1, Oncotarget, 7:57811-57820.
PJ Davis, GV Glinsky, HY Lin, SA Mousa (2016) Actions of thyroid hormone analogues on chemokines, J Immunol Res, 2016:3147671.
A Hercbergs, PJ Davis, HY Lin, SA Mousa (2016) Possible contributions of thyroid hormone replacement to specific behaviors of cancer, Biomed Pharmacother, 84:655-659.
HY Lin, YT Chin, AW Nana, YJ Shih, HY Lai, HY Tang, M Leinung, SA Mousa, PJ Davis (2016) Actions of L-thyroxine and nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells, Steroids, 114:59-67.
V Muralidharan-Chari, J Kim, A Abuawad, M Naeem, HD Cui, SA Mousa (2016) Thymoquinone modulates blood coagulation in vitro via its effects on inflammatory and coagulation pathways, Int J Mol Sci, 17:474.
V Muralidharan-Chari, HG Kohan, AG Asimakopoulos, T Sudha, S Sell, K Kannan, M Boroujerdi, PJ Davis, SA Mousa (2016) Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells, Oncotarget, 7:50365-50379.
V Muralidharan-Chari, SA Mousa (2016) Heparin neutralizer anticoagulant reversal agent, Drugs of the Future, 41:341-346.
M Rajabi, SA Mousa (2016) Lipid nanoparticles and their application in nanomedicine, Curr Pharm Biotech, 17:662-672.
M Rajabi, T Sudha, NHE Darwish, PJ Davis, SA Mousa (2016) Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator, Bioorg Med Chem Lett, 26:4112-4116.
PJ Davis, T Sudha, HY Lin, SA Mousa (2015) Thyroid hormone, hormone analogs, and angiogenesis, Compr Physiol, 6:353-362.
HY Lin, GV Glinsky, SA Mousa, PJ Davis (2015) Thyroid hormone and anti-apoptosis in tumor cells, Oncotarget, 6:14735-14743.
M Rajabi, Z Hossaini, MA Khalilzadeh, S Datta, M Halder, SA Mousa (2015) Synthesis of a new class of furo [3,2-c] coumarins and its anticancer activity, J Photochem Photobiol B, 148:66-72.
AMA Safer, NA Hanafy, DJ Bharali, HD Cui, SA Mousa (2015) Effect of green tea extract encapsulated into chitosan nanoparticles on hepatic fibrosis collagen fibers assessed by atomic force microscopy in rat hepatic fibrosis model, J Nanosci Nanotech, 15:6452-6459.
A Bani-Jaber, H Cui, A Elsaid, M Yalcin, T Sudha, SA Mousa (2015) Pegylated Solid Lipid Nanoparticles Reconstituted From High-Density Lipoprotein components for Hepatic Targeting. ScienceJet 4:145. http://www.cognizure.com/sj.aspx?p=200638605
PJ Davis, GV Glinsky, HY Lin, JT Leith, A Hercbergs, HY Tang, O Ashur-Fabian, S Incerpi, SA Mousa (2015) Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac. Front Endocrinol 5:240. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290672/
A Alshaiban, V Muralidharan-Chari, A Nepo, SA Mousa (2015) Modulation of Sickle Red Blood Cell Adhesion and Its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative. Clin Appl Thromb Hemost 22:230-238. http://www.ncbi.nlm.nih.gov/pubmed/25601897
R Alyahya, T Sudha, M Racz, SC Stain, SA Mousa (2015) Anti-Metastasis Efficacy and Safety of Non-Anticoagulant Heparin Derivative Versus Low Molecular Weight Heparin in Surgical Pancreatic Cancer Models. Int J Oncol 46:1225-1231. http://www.spandidos-publications.com/ijo/46/3/1225
PJ Davis, HY Lin, T Sudha, M Yalcin, HY Tang, A Hercbergs, JT Leith, MK Luidens, O Ashur-Fabian, S Incerpi, SA Mousa (2014) Nanotetrac Targets Integrin Alphavbeta3 on Tumor Cells to Disorder Cell Defense Pathways and Block Angiogenesis. Onco Targets Ther 7:1619-1624. Nanotetrac Targets Integrin Alphavbeta3 on Tumor Cells
IA Siddiqui, DJ Bharali, M Nihal, VM Adhami, N Khan, JC Chamcheu, MI Khan, S Shabana, SA Mousa, H Mukhtar (2014) Excellent Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3-Gallate Encapsulated in Chitosan Nanoparticles on Human Melanoma Cell Growth Both in Vitro and in Vivo. Nanomedicine 10:1619-1626. http://www.sciencedirect.com/science/article/pii/S1549963414002202
T Sudha, M Yalcin, HY Lin, AM Elmetwally, T Nazeer, T Arumugam, P Phillips, SA Mousa (2014) Suppression of Pancreatic Cancer by Sulfated Non-Anticoagulant Low Molecular Weight Heparin. Cancer Letters 350:25-33. http://www.ncbi.nlm.nih.gov/pubmed/24769074
SA Mousa, HY Lin, HY Tang, A Hercbergs, MK Luidens, PJ Davis (2014) Modulation of Angiogenesis by Thyroid Hormone and Hormone Analogues: Implications for Cancer Management. Angiogenesis 17:463-469. http://www.ncbi.nlm.nih.gov/pubmed/24458693
N Khan, DJ Bharali, VM Adhami, IA Siddiqui, H Cui, SM Shabana, SA Mousa, H Mukhtar (2014) Oral Administration of Naturally Occurring Chitosan-Based Nanoformulated Green Tea Polyphenol Egcg Effectively Inhibits Prostate Cancer Cell Growth in a Xenograft Model. Carcinogenesis 35:415-423. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908746/
M Yalcin, HY Lin, T Sudha, DJ Bharali, R Meng, HY Tang, FB Davis, SC Stain, PJ Davis, SA Mousa (2013) Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles. Hormones and Cancer 4:176-185. http://www.ncbi.nlm.nih.gov/pubmed/23456390
SA Mousa (2013) Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions: Structure-Function Relationship. Clinical and Applied Thrombosis/Hemostasis 19:48-54. http://www.ncbi.nlm.nih.gov/pubmed/22327829
HY Lin, YF Su, MT Hsieh, S Lin, R Meng, D London, C Lin, HY Tang, J Hwang, FB Davis, SA Mousa, PJ Davis (2013) Nuclear Monomeric Integrin Alphav in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone. FASEB Journal 27:3209-3216. http://www.fasebj.org/content/27/8/3209.long
PJ Davis, SA Mousa, V Cody, HY Tang, HY Lin (2013) Small Molecule Hormone or Hormone-Like Ligands of Integrin Alphavbeta3: Implications for Cancer Cell Behavior. Hormes and Cancer 4:335-342. http://www.ncbi.nlm.nih.gov/pubmed/23943159
PJ Davis, HY Lin, HY Tang, FB Davis, SA Mousa (2013) Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone. Thyroid 23:1503-1509. http://www.ncbi.nlm.nih.gov/pubmed/24011085
T Sudha, P Phillips, C Kanaan, RJ Linhardt, L Borsig, SA Mousa (2012) Inhibitory Effect of Non-Anticoagulant Heparin (S-Nach) on Pancreatic Cancer Cell Adhesion and Metastasis in Human Umbilical Cord Vessel Segment and in Mouse Model. Clin Exp Metastasis 29:431-439. http://www.ncbi.nlm.nih.gov/pubmed/22415710
MH Qari, U Dier, SA Mousa (2012) Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients with Sickle Cell Disease. Clinical and Applied Thrombosis/Hemostasis 18:195-200. http://www.ncbi.nlm.nih.gov/pubmed/21949038
SA Mousa, M Yalcin, DJ Bharali, R Meng, HY Tang, HY Lin, FB Davis, PJ Davis (2012) Tetraiodothyroacetic Acid and Its Nanoformulation Inhibit Thyroid Hormone Stimulation of Non-Small Cell Lung Cancer Cells in Vitro and Its Growth in Xenografts. Lung Cancer 76:39-45. http://www.ncbi.nlm.nih.gov/pubmed/22024450
HY Lin, HY Tang, FB Davis, SA Mousa, S Incerpi, MK Luidens, R Meng, PJ Davis (2012) Nongenomic Regulation by Thyroid Hormone of Plasma Membrane Ion and Small Molecule Pumps. Discovery Medicine 14:199-206. Nongenomic Regulation by Thyroid Hormone